420 results on '"Holmøy, Trygve"'
Search Results
2. Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with anti-glycine receptor antibodies and urothelial carcinoma: a case report
3. Tuberculin responses after BCG vaccination predict amyotrophic lateral sclerosis risk
4. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy
5. Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
6. Skogholt’s disease—A tauopathy precipitated by iron and copper?
7. Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
8. Faible activité de la maladie après un traitement de 4 ans par ocrelizumab (OCR) chez des patients naïfs de traitement atteints de sclérose en plaques récurrente-rémittente (SEP-RR) à un stade précoce ; données de l’étude de phase IIIb ensemble
9. 'Assisting their orphaned children when in need'
10. BCG vaccination and multiple sclerosis risk: A Norwegian cohort study
11. Norwegian health service should offer stem cell therapy for multiple sclerosis
12. Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19
13. Physical Activity, Fitness, and Long-Term Risk of Amyotrophic Lateral Sclerosis: A Prospective Cohort Study.
14. Premorbid lipid levels and long-term risk of ALS—a population-based cohort study.
15. Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway.
16. Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis
17. En kvinne i 60-årene som ikke lenger gjenkjente det hun så
18. An Update on Vitamin D and Disease Activity in Multiple Sclerosis
19. Association of Body Mass Index in Adolescence and Young Adulthood and Long-term Risk of Multiple Sclerosis: A Population-Based Study
20. B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate
21. «At komme deres værdige og trængende Efterladte til Hjælp».
22. Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders.
23. Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease.
24. Norsk helsevesen bør tilby stamcellebehandling mot multippel sklerose.
25. CSF, Blood, and MRI Biomarkers in Skogholt’s Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred
26. Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders
27. Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease
28. Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis
29. T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
30. A Novel SPAST Variant Associated with Isolated Spastic Paraplegia.
31. Serum sickness following rituximab therapy in multiple sclerosis
32. Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a
33. Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway
34. Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults
35. Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis
36. Body mass index influence interferon-beta treatment response in multiple sclerosis
37. High BMI is associated with low ALS risk: A population-based study
38. Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
39. Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
40. Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome
41. Iron and copper in progressive demyelination – New lessons from Skogholt's disease
42. Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
43. Mortality trends of amyotrophic lateral sclerosis in Norway 1951–2014: an age–period–cohort study
44. Breastfeeding and treatment for multiple sclerosis
45. A. H. Ali og medarbeidere svarer
46. Prevalence and predictors of long COVID among non-hospitalised adolescents and young adults: a prospective controlled cohort study
47. The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
48. T cell responses to SARS-CoV-2 vaccination in people with multiple sclerosis differ between disease-modifying therapies
49. Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
50. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.